1. Home
  2. NVAX vs AHCO Comparison

NVAX vs AHCO Comparison

Compare NVAX & AHCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NVAX
  • AHCO
  • Stock Information
  • Founded
  • NVAX 1987
  • AHCO 2012
  • Country
  • NVAX United States
  • AHCO United States
  • Employees
  • NVAX N/A
  • AHCO N/A
  • Industry
  • NVAX Biotechnology: Biological Products (No Diagnostic Substances)
  • AHCO Medical/Nursing Services
  • Sector
  • NVAX Health Care
  • AHCO Health Care
  • Exchange
  • NVAX Nasdaq
  • AHCO Nasdaq
  • Market Cap
  • NVAX 1.3B
  • AHCO 1.2B
  • IPO Year
  • NVAX 1995
  • AHCO N/A
  • Fundamental
  • Price
  • NVAX $6.00
  • AHCO $7.79
  • Analyst Decision
  • NVAX Buy
  • AHCO Strong Buy
  • Analyst Count
  • NVAX 6
  • AHCO 5
  • Target Price
  • NVAX $17.83
  • AHCO $13.80
  • AVG Volume (30 Days)
  • NVAX 6.0M
  • AHCO 1.8M
  • Earning Date
  • NVAX 05-09-2025
  • AHCO 05-06-2025
  • Dividend Yield
  • NVAX N/A
  • AHCO N/A
  • EPS Growth
  • NVAX N/A
  • AHCO N/A
  • EPS
  • NVAX N/A
  • AHCO 0.61
  • Revenue
  • NVAX $682,162,000.00
  • AHCO $3,260,975,000.00
  • Revenue This Year
  • NVAX $1.07
  • AHCO $2.21
  • Revenue Next Year
  • NVAX N/A
  • AHCO $4.83
  • P/E Ratio
  • NVAX N/A
  • AHCO $12.77
  • Revenue Growth
  • NVAX N/A
  • AHCO 1.90
  • 52 Week Low
  • NVAX $3.81
  • AHCO $7.81
  • 52 Week High
  • NVAX $23.86
  • AHCO $11.90
  • Technical
  • Relative Strength Index (RSI)
  • NVAX 41.41
  • AHCO 28.72
  • Support Level
  • NVAX $5.01
  • AHCO $8.66
  • Resistance Level
  • NVAX $6.58
  • AHCO $9.87
  • Average True Range (ATR)
  • NVAX 0.65
  • AHCO 0.57
  • MACD
  • NVAX 0.02
  • AHCO -0.27
  • Stochastic Oscillator
  • NVAX 50.25
  • AHCO 2.03

About NVAX Novavax Inc.

Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. It works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The company manages its business as one operating segment, the development and commercialization of vaccines. The company generates maximum revenue from the United States.

About AHCO AdaptHealth Corp.

AdaptHealth Corp is engaged in providing patient-centered, healthcare-at-home solutions including home medical equipment (HME), medical supplies, and related services. It focuses on providing; sleep therapy equipment, supplies, and related services (including CPAP and bi-PAP services) to individuals suffering from obstructive sleep apnea (OSA), medical devices and supplies to patients for the treatment of diabetes (including continuous glucose monitors (CGM and insulin pumps), home medical equipment to patients discharged from acute care and other facilities, oxygen and related chronic therapy services in the home, and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy and nutritional supply needs.

Share on Social Networks: